Publication | Open Access
The Incidence of Ototoxicity in Patients Using Iron Chelators
15
Citations
8
References
2016
Year
The ototoxicity incidence with DFO at doses below 50 mg/kg/day was 27.3%. Deferiprone and deferasirox were not associated with ototoxic effects in patients taking these drugs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1